Immunotherapy targeting a leader sequence cathepsin G-derived peptide: IMMUNOTHERAPY靶向一种源自组织蛋白酶G的信号序列肽的免疫疗法:IMMUNOTHERAPYLEUKEMIAIF13.42025-02-121OA
Preclinical development of 1B7/CD3, a novel antiTSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (vol 37, pg 2006, 2023)LEUKEMIAIF13.42023-11-300OAAI
Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALLLEUKEMIAIF13.42023-08-262OAAI
preclinical development of a novel anti-tslpr bispecific antibody 1b7/cd3 targeting crlf2-rearranged ph-like b-allCANCER RESEARCHIF16.62023-04-040PRE